Vaccines,therapeutic clin trials to boost COVID prevention & treatment

The European Commission has launched a call, COVID19 - HERA Incubator, that will mobilize all means and resources necessary to prevent, mitigate and respond to the potential impact of COVID-19 variants.

The European Commission has launched a call, COVID19 - HERA Incubator, that will mobilize all means and resources necessary to prevent, mitigate and respond to the potential impact of COVID-19 variants.
April 13, 2021

The European Commission has launched a call, COVID19 – HERA Incubator (HORIZON-HLTH-2021-CORONA-01), that will mobilize all means and resources necessary to prevent, mitigate and respond to the potential impact of COVID-19 variants.

This specific call aims at supporting activities that enable the conduct of vaccine & therapeutic trials to boost prevention and further inform public health policy and clinical management. Proposals submitted under this expression of interest should aim to further develop promising therapeutic or prophylactic candidates against SARS-CoV-2/COVID-19

Asphalion is actively involved in several European granted H2020 projects consortium as partner, taking care of the regulatory activities during the development of different innovative products. Furthermore, Asphalion is already participating as a Regulatory Partner in different COVID-19 related projects.

In case you need further information please contact us at: [email protected]

Search News & Events

  • Filter by category

Share

Related news and events

NEWS | Important Update from the FDA!

This guidance recommends steps manufacturers and applicants of active pharmaceutical ingredients (APIs) and drug products should take to detect and prevent unacceptable levels of nitrosamine impurities in drug products. The guidance also describes conditions that may introduce nitrosamine impurities. The unexpected finding of nitrosamine impurities, which are probable or possible human carcinogens, in certain drug products has made clear the need for a risk assessment strategy for the potential presence of nitrosamines in any drug product.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting